Other News

Arch Biopartners Announces Dosing of First Patient in Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing has begun in Turkey for the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury […]

Premier Radiology Services Signs 5-Year Agreement to use RamSoft’s OmegaAI™ and Cloud-Based PowerServer® RIS/PACS Platforms for its 1,000+ Teleradiology Sites

RamSoft’s robust solutions provide Premier with unmatched speed and reliability for reading and processing images for its fast-growing teleradiology operations TORONTO and MIAMI, March 7, 2024 /PRNewswire/ – RamSoft, a global leader in novel cloud-based RIS/PACS radiology solutions for…

Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions

HANGZHOU, China, March 7, 2024 /PRNewswire/ — Zylox-Tonbridge (2190.HK, “the Company”), a leading medical device company in the peripheral and neurovascular interventional market in China, today announced a new strategic partnership with Avinger, a commercial-stage medical device company…

UltraNav Transseptal System will present at “Best Interesting Case” at CRT

Unique new dual-lumen catheter enables safer, more cost-effective transeptal crossing and left atrial access, improving cardiologist and patient experience; CRT “Best Interesting Case” highlights left appendage closure device implantation without the need for TEE or anesthesia SCOTTSDALE, Ariz., March 5, 2024 /PRNewswire/ — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal […]

AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Oppenheimer 34th Annual Virtual Healt

La Jolla Vein & Vascular Proudly Announces World Lymphedema Day Patient Education Event

LA JOLLA, Calif.–(BUSINESS WIRE)–La Jolla Vein & Vascular, a leading provider of vascular health services in the San Diego area, is excited to announce their upcoming event today, the World Lymphedema Day Patient Education Event. This informative and educational function is scheduled to take place on March 6, 2024, in the practice lobby of La Jolla Vein & Vascular. Lymphedema, a condition affecting many individuals around the world, is a chronic disorder that can have a significant im

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Southlake, TX, March 06, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that the Canadian Intellectual Property Office Application […]

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

– Record fourth quarter 2023 CGuard EPS revenue of $1.76 million increased 71.6% over fourth quarter 2022 – – Announced positive 30-day data from the Company’s ongoing U.S. Investigational Device Exemption (IDE) clinical trial, C-GUARDIANS, designed to support U.S. approval of CGuard Prime – – Named Patrick Geraghty, M.D. and […]

Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting

SOUTH JORDAN, Utah, March 05, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today a series of events for clinicians attending the 2024 SIR Annual Meeting. These educational events will take place at Merit’s headquarters and at SIR booth 320. On […]